Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 102335
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102335
Table 1 Baseline characteristics in non-post-hepatectomy liver failure and post-hepatectomy liver failure groups, n (%)
Variable
Total (n = 285)
Non-PHLF (n = 221)
PHLF (n = 64)
P value
Preoperative risk factors
Gender---0.008
Male141 (49.5)100 (45.2)41 (64.1)-
Female144 (50.5)121 (54.8)23 (35.9)-
Age (years)54.0 (48.0-61.0)54.0 (47.0-61.0)55.0 (49.0-62.0)0.264
BMI (kg/m2), mean ± SD22.5 ± 2.822.3 ± 2.822.9 ± 3.00.197
LOS (d), mean ± SD18.1 ± 7.516.6 ± 5.923.2 ± 9.8< 0.001
History of hepatitis---0.046
No198 (69.5)160 (72.4)38 (59.4)-
Yes87 (30.5)61 (27.6)26 (40.6)-
Cirrhosis---< 0.001
No203 (71.2)174 (78.7)29 (45.3)-
Yes82 (28.8)47 (21.3)35 (54.7)-
Jaundice---0.001
No254 (89.1)204 (92.3)50 (78.1)-
Yes31 (10.9)17 (7.7)14 (21.9)
Ascites---0.263
No252 (89.7)197 (90.8)55 (85.9)-
Yes29 (10.3)20 (9.2)9 (14.1)-
Child-Pugh score---< 0.001
5211 (74.0)174 (78.7)37 (57.8)-
645 (15.8)34 (15.4)11 (17.2)-
721 (7.4)9 (4.1)12 (18.8)-
86 (2.1)3 (1.4)3 (4.7)-
92 (0.7)1 (0.5)1 (1.6)-
Cause of liver resection---< 0.001
Tumor122 (42.8)81 (36.7)41 (64.1)-
Other163(57.2)140 (63.3)23(35.9)
TC (mmol/L)4.4 ± 1.14.4 ± 1.04.2 ± 1.40.299
LDL-C (mmol/L)2.6 (2.1-3.2)2.6 (2.1-3.2)2.4 (2.1-3.0)0.206
TG (mmol/L)1.2 (0.8-1.8)1.2 (0.8-1.8)1.0 (0.8-1.6)0.515
Neutrophils (109/L)3.4 (2.6-4.6)3.5 (2.6-4.7)3.2 (2.5- 4.4)0.332
Lymphocytes (109/L), mean ± SD1.6 ± 0.61.7 ± 0.61.4 ± 0.50.004
Leukocytes (109/L)5.7 (4.6-7.1)5.8 (4.7-7.2)5.3 (4.3-6.7)0.059
Platelets (109/L)200.5 (149.0-264.0)213.0 (163.0-264.0)153.0 (108.0-249.5)< 0.001
Hemoglobin (g/L)128.4 ± 18.4128.7 ± 16.4127.3 ± 24.10.596
Albumin (g/L)40.6 ± 5.141.2 ± 4.938.4 ± 5.1< 0.001
TBIL (μmol/L)14.9 (11.4-20.8)14.5 (11.0-20.2)17.0 (12.4-29.7)0.012
DBIL (μmol/L)5.0 (3.7-7.7)4.8 (3.6-7.2)5.5 (4.2-12.3)0.005
ALT (U/L)31.4 (19.0-56.4)28.8 (18.0-50.7)46.3 (28.1-66.5)0.001
AST (U/L)28.4 (21.8-45.2)26.2 (20.8-39.2)38.8 (28.7-52.6)< 0.001
Intraoperative risk factors
Operation mode---0.611
Laparoscopic153 (53.7)122 (55.2)31 (48.4)-
Open119 (41.8)89 (40.3)30 (46.9)-
Conversion from laparoscopic to open13 (4.6)10 (4.5)3 (4.7)-
Extensive resection---0.09
No160 (56.1)130 (58.8)30 (46.9)-
Yes125 (43.9)91 (41.2)34 (53.1)-
Operation time (min)327.7 ± 154.9306.2 ± 134.4401.8 ± 194.4< 0.001
Liver blockage time (min)41.0 (22.0-72.0)38.0 (21.0-63.0)58.0 (24.0-95.0)0.003
Number of blocks3.0 (1.0-4.0)2.0 (1.0-4.0)4.0 (2.0-6.0)0.002
Total amount volume (mL), mean ± SD2684.2 ± 1155.32490.7 ± 901.63352.6 ± 1610.2< 0.001
Blood loss volume (mL)200.0 (100.0-400.0)200.0 (100.0-300.0)300.0 (200.0-800.0)< 0.001
Infusion of blood products---0.001
No254 (89.1)204 (92.3)50 (78.1)-
Yes31 (10.9)17 (7.7)14 (21.9)-
Urine volume (mL)500.0 (300.0-950.0)500.0 (300.0-800.0)700.0 (362.5-1137.5)0.001
Infusion of albumin---0.523
No71 (24.9)57 (25.8)14 (21.9)-
Yes214 (75.1)164 (74.2)50 (78.1)-
Pre-blocking PCO2 (mmHg)42.0 (37.0-48.0)43.0 (37.0-48.0)42.0 (37.0-49.0)0.91
Post-blocking PCO2 (mmHg)43.0 (36.0-49.0)43.5 (36.0-48.2)43.0 (37.0-50.0)0.535
Pre-blocking potassium (mmol/L)3.7 (3.4-4.0)3.6 (3.4-3.9)3.7 (3.5-4.0)0.15
Post-blocking potassium (mmol/L)4.0 ± 0.63.9 ± 0.64.3 ± 0.6< 0.001
Pre-blocking glucose (mmol/L)5.8 (5.2-6.8)5.8 (5.2-6.7)6.2 (5.4-7.3)0.25
Post-blocking glucose (mmol/L)9.2 (7.0-11.1)8.9 (7.0-11.0)9.3 (7.0-11.0)0.768
Pre-blocking lactic acid (mmol/L)0.8 (0.6-1.2)0.8 (0.6-1.2)1.0 (0.7-1.4)0.019
Post-blocking lactic acid (mmol/L)1.6 (1.1-2.3)1.4 (1.0-2.0)2.0 (1.3-3.0)< 0.001
Table 2 Univariate and multivariate logistic analyses for preoperative risk factors
VariableUnivariate logistic regression analysis
Multivariate logistic regression analysis
OR, 95%CI
P value
OR, 95%CI
P value
Preoperative serum albumin level0.89 (0.84-0.95)< 0.0010.93 (0.87-1)0.036
Lymphocytes (109/L)0.45 (0.26-0.78)0.0040.81 (0.41-1.61)0.55
PLT (109/L)0.99 (0.99-1)0.0011 (0.99-1)0.212
Prothrombin time (s)1.35 (1.09-1.67)0.0061.19 (0.8-1.77)0.389
Prothrombin activity level (%)0.99 (0.98-1)0.0431 (0.98-1.02)0.822
TBIL (μmol/L)1.02 (1.01-1.03)0.0011 (0.96-1.05)0.917
DBIL (μmol/L)1.03 (1.01-1.05)0.0021.01 (0.95-1.09)0.697
Causes of liver resection, (cancer or others)0.32 (0.18-0.58)< 0.0010.39 (0.16-0.94)0.037
Gender2.16 (1.21-3.83)0.0091.55 (0.75-3.19)0.238
History of viral hepatitis1.79 (1.01-3.2)0.0480.72 (0.29-1.82)0.492
Cirrhosis4.47 (2.48-8.05)< 0.0013.1 (1.56-6.17)0.001
Jaundice3.36 (1.55-7.27)0.0020.98 (0.28-3.42)0.972
Table 3 Univariate and multivariate logistic analyses for intraoperative risk factors
VariableUnivariate logistic regression analysis
Multivariate logistic regression analysis
OR, 95%CI
P value
OR, 95%CI
P value
Urinary production (mL)1.001 (1-1.001)< 0.0011 (1-1)0.593
Blood loss volume (mL)1.002 (1.001-1.002)< 0.0011 (1-1)0.567
Infusion fluid volume (mL)1.001 (1-1.001)< 0.0011 (1-1)0.148
Blood transfusion3.36 (1.553-7.272)0.0020.94 (0.25-3.56)0.93
Operation time (min)1.004 (1.002-1.006)< 0.0011 (1-1)0.954
Hepatic portal occlusion time (min)1.014 (1.007-1.021)< 0.0011.01 (0.97-1.04)0.641
Number of blocks1.255 (1.12-1.406)< 0.0010.93 (0.55-1.57)0.787
Post-blocking blood potassium (mmol/L)2.222 (1.362-3.627)0.0011.82 (1.05-3.17)0.033
Post-blocking blood lactate (mmol/L)1.491 (1.164-1.908)0.0021.08 (0.8-1.46)0.629
Table 4 Baseline characteristics in training and validation groups, n (%)
Variable
Total (n = 285)
Training group (n = 199)
Validation group (n = 85)
P value
PHLF (%)---0.504
No221157 (78.9)64 (75.3)-
Yes6442 (21.1)21 (24.7)-
Preoperative risk factors
Gender---0.98
Male141 (49.5)101 (50.8)43 (50.6)-
Female144 (50.5)98 (49.2)42 (49.4)-
Age (years)54.0 (48.0-61.0)54.0 (48.0-61.0)55.0 (49.0-62.0)0.262
BMI (kg/m2), mean ± SD22.5 ± 2.822.4 ± 2.822.6 ± 2.90.551
LOS (d), mean ± SD18.1 ± 7.517.7 ± 7.019.0 ± 8.50.175
History of hepatitis---0.266
No198 (69.5)142 (71.4)55 (64.7)-
Yes87 (30.5)57 (28.6)30 (35.3)-
Cirrhosis---0.52
No203 (71.2)140 (70.4)63 (74.1)-
Yes82 (28.8)59 (29.6)22 (25.9)-
Jaundice---0.474
No254 (89.1)179 (89.9)74 (87.1)-
Yes31 (10.9)20 (10.1)11 (12.9)-
Ascites---0.572
No252 (89.7)180 (90.5)75 (88.2)-
Yes29 (10.3)19 (9.5)10 (11.8)-
Child-Pugh score--0.198
5211 (74.0)144 (72.4)66 (77.6)-
645 (15.8)35 (17.6)10 (11.8)-
721 (7.4)16 (8)5 (5.9)-
86 (2.1)4 (2)2 (2.4)-
92 (0.7)0 (0)2 (2.4)-
Cause of liver resection---0.041
Tumor122 (42.8)77 (38.7)44 (51.8)-
Other163(57.2)122 (61.3)41 (48.2)-
TC (mmol/L), mean ± SD4.4 ± 1.14.3 ± 1.14.4 ± 1.10.625
LDL-C (mmol/L)2.6 (2.1-3.2)2.5 (2.1-3.2)2.7 (2.1-3.0)0.816
TG (mmol/L)1.2 (0.8-1.8)1.2 (0.8-1.7)1.1 (0.8-1.9)0.941
Neutrophils (109/L)3.4 (2.6-4.6)3.5 (2.6-4.6)3.4 (2.6-4.6)0.698
Lymphocytes (109/L)1.6 ± 0.61.6 ± 0.61.6 ± 0.50.447
Leukocytes (109/L)5.7 (4.6-7.1)5.7 (4.7-7.2)5.6 (4.5-7.0)0.738
Platelets (109/L)200.5 (149.0-264.0)199.0 (149.0-259.0)206.0 (156.0-279.0)0.587
Hemoglobin (g/L)128.4 ± 18.4127.8 ± 18.1129.9 ± 19.10.382
Albumin (g/L)40.6 ± 5.140.4 ± 5.241.0 ± 4.80.394
TBIL (μmol/L)14.9 (11.4-20.8)14.8 (10.9-22.4)15.2 (11.9-19.8)0.873
DBIL (μmol/L)5.0 (3.7-7.7)5.1 (3.7-7.8)4.8 (4.0-7.6)0.969
ALT (U/L)31.4 (19.0-56.4)31.5 (19.6-59.0)30.0 (18.5-46.3)0.230
AST (U/L)28.4 (21.8-45.2)28.9 (21.6-46.0)28.1 (22.0-44.6)0.905
Intraoperative risk factors
Operation mode---0.378
Laparoscopic153 (53.7)107 (53.8)46 (54.1)-
Open119 (41.8)85 (42.7)33 (38.8)-
Conversion from laparoscopic to open13 (4.6)7 (3.5)6 (7.1)-
Extensive resection---0.416
No160 (56.1)109 (54.8)51 (60)-
Yes125 (43.9)90 (45.2)34 (40)-
Operation length (min), mean ± SD327.7 ± 154.9322.1 ± 155.8340.5 ± 153.70.360
Liver blockage time (min)41.0 (22.0-72.0)40.0 (18.2-68.0)43.0 (28.0-75.0)0.294
Number of blocks3.0 (1.0-4.0)3.0 (1.0-4.0)3.0 (2.0-5.0)0.520
Total amount volume (mL), mean ± SD2684.2 ± 1155.32696.7 ± 1134.02647.2 ± 1214.20.742
Blood loss volume (mL)200.0 (100.0-400.0)200.0 (100.0-400.0)200.0 (150.0-400.0)0.102
Infusion of blood products---0.344
No254 (89.1)175 (87.9)78 (91.8)-
Yes31 (10.9)24 (12.1)7 (8.2)-
Urine volume (mL)500.0 (300.0-950.0)500.0 (300.0-912.5)500.0 (300.0-1000.0)0.995
Infusion of albumin---0.752
No71 (24.9)48 (24.1)22 (25.9)-
Yes214 (75.1)151 (75.9)63 (74.1)-
Pre-blocking PCO2 (mmHg)42.0 (37.0-48.0)42.0 (37.0-49.0)42.0 (35.0-47.0)0.480
Post-blocking PCO2 (mmHg)43.0 (36.0-49.0)43.0 (36.0-49.0)44.0 (36.0-49.5)0.805
Pre-blocking potassium (mmol/L)3.7 (3.4-4.0)3.6 (3.3-3.9)3.7 (3.5-4.0)0.072
Post-blocking potassium (mmol/L), mean ± SD4.0 ± 0.64.0 ± 0.64.1 ± 0.70.082
Pre-blocking glucose (mmol/L)5.8 (5.2-6.8)5.8 (5.2-6.8)5.8 (5.2*6.8)0.876
Post-blocking glucose (mmol/L)9.2 (7.0-11.1)8.9 (7.0-10.8)9.5 (7.5*11.4)0.181
Pre-blocking lactic acid (mmol/L)0.8 (0.6-1.2)0.8 (0.6-1.2)0.8 (0.7-1.2)0.744
Post-blocking lactic acid (mmol/L)1.6 (1.1-2.3)1.5 (1.0-2.2)1.6 (1.2-2.5)0.284
Table 5 Variable filtering
Number
Variable, name
Coefficient
Lambda, type
Lambda, P value
0Intercept-0.63Lambda1se0.049
1Gender-Lambda1se0.049
2History of viral hepatitis-Lambda1se0.049
3Cirrhosis0.768Lambda1se0.049
4Jaundice-Lambda1se0.049
5Causes of liver resection (cancer or others)-0.37Lambda1se0.049
6Lymphocyte count (109/L)-Lambda1se0.049
7PLT (109/L)0Lambda1se0.049
8Preoperative serum albumin level-0.028Lambda1se0.049
9TBIL (μmol/L)-Lambda1se0.049
10DBIL (μmol/L)0.01Lambda1se0.049
11Prothrombin time (second)-Lambda1se0.049
12Prothrombin activity level (%)-Lambda1se0.049